Literature DB >> 9781519

Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease.

C R Jack1, R C Petersen, Y Xu, P C O'Brien, G E Smith, R J Ivnik, E G Tangalos, E Kokmen.   

Abstract

OBJECTIVES: To determine the annual rates of volumetric change of the hippocampus and temporal horn in cognitively normal elderly control subjects and individually matched patients with AD, and to test the hypothesis that these rates were different.
BACKGROUND: Cross-sectional studies consistently reveal cerebral atrophy in elderly nondemented subjects compared with healthy young adults, and greater atrophy in patients with AD relative to elderly control subjects. However, rates of atrophy are estimated most accurately by performing serial measurements in the same individuals.
METHODS: MRI-based volumetric measurements of the hippocampi and temporal horns were performed in 24 cognitively normal subjects aged 70 to 89 years who were individually matched with respect to gender and age with 24 patients with AD. Each subject underwent an MRI protocol twice, separated by 12 months or more.
RESULTS: The mean annual rate of hippocampal volume loss among control subjects was -1.55+/-1.38% and the temporal horns increased in volume by 6.15+/-7.69% per year. These rates were significantly greater among AD patients: hippocampus, -3.98+/-1.92% per year, p < 0.001; temporal horn, 14.16+/-8.47% per year, p = 0.002.
CONCLUSION: A statistically significant yearly decline in hippocampal volume and an increase in temporal horn volume was identified in elderly control subjects who represent typical aging individuals. These rates were approximately 2.5 times greater in patients with AD than in individually age- and gender-matched control subjects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781519      PMCID: PMC2768817          DOI: 10.1212/wnl.51.4.993

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  39 in total

1.  Age-related differences in volumes of subcortical nuclei, brain matter, and cerebrospinal fluid in healthy men as measured with magnetic resonance imaging.

Authors:  D G Murphy; C DeCarli; M B Schapiro; S I Rapoport; B Horwitz
Journal:  Arch Neurol       Date:  1992-08

2.  Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging.

Authors:  C E Coffey; W E Wilkinson; I A Parashos; S A Soady; R J Sullivan; L J Patterson; G S Figiel; M C Webb; C E Spritzer; W T Djang
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

3.  Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease.

Authors:  G D Pearlson; G J Harris; R E Powers; P E Barta; E E Camargo; G A Chase; J T Noga; L E Tune
Journal:  Arch Gen Psychiatry       Date:  1992-05

4.  Gender differences in age effect on brain atrophy measured by magnetic resonance imaging.

Authors:  R C Gur; P D Mozley; S M Resnick; G L Gottlieb; M Kohn; R Zimmerman; G Herman; S Atlas; R Grossman; D Berretta
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

5.  Senile dementia and healthy aging: a longitudinal CT study.

Authors:  F J Wippold; M H Gado; J C Morris; J M Duchek; E A Grant
Journal:  Radiology       Date:  1991-04       Impact factor: 11.105

6.  Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type.

Authors:  C DeCarli; J V Haxby; J A Gillette; D Teichberg; S I Rapoport; M B Schapiro
Journal:  Neurology       Date:  1992-10       Impact factor: 9.910

7.  The significance of age-related enlargement of the cerebral ventricles in healthy men and women measured by quantitative computed X-ray tomography.

Authors:  J A Kaye; C DeCarli; J S Luxenberg; S I Rapoport
Journal:  J Am Geriatr Soc       Date:  1992-03       Impact factor: 5.562

8.  Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease.

Authors:  J P Kesslak; O Nalcioglu; C W Cotman
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

9.  MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease.

Authors:  C R Jack; R C Petersen; P C O'Brien; E G Tangalos
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

10.  Brain atrophy in hypertension. A volumetric magnetic resonance imaging study.

Authors:  J A Salerno; D G Murphy; B Horwitz; C DeCarli; J V Haxby; S I Rapoport; M B Schapiro
Journal:  Hypertension       Date:  1992-09       Impact factor: 10.190

View more
  199 in total

1.  Loss of presynaptic and postsynaptic structures is accompanied by compensatory increase in action potential-dependent synaptic input to layer V neocortical pyramidal neurons in aged rats.

Authors:  T P Wong; G Marchese; M A Casu; A Ribeiro-da-Silva; A C Cuello; Y De Koninck
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

2.  Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain.

Authors:  Susan M Resnick; Dzung L Pham; Michael A Kraut; Alan B Zonderman; Christos Davatzikos
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

3.  SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography.

Authors:  E P Bouras; S Delgado-Aros; M Camilleri; E J Castillo; D D Burton; G M Thomforde; H J Chial
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

4.  3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.

Authors:  Liana G Apostolova; Kristy S Hwang; John P Andrawis; Amity E Green; Sona Babakchanian; Jonathan H Morra; Jeffrey L Cummings; Arthur W Toga; John Q Trojanowski; Leslie M Shaw; Clifford R Jack; Ronald C Petersen; Paul S Aisen; William J Jagust; Robert A Koeppe; Chester A Mathis; Michael W Weiner; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2010-06-11       Impact factor: 4.673

5.  Age-related cerebral atrophy in nonhuman primates predicts cognitive impairments.

Authors:  Jean-Luc Picq; Fabienne Aujard; Andreas Volk; Marc Dhenain
Journal:  Neurobiol Aging       Date:  2010-10-22       Impact factor: 4.673

6.  MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

Authors:  C R Jack; M Slomkowski; S Gracon; T M Hoover; J P Felmlee; K Stewart; Y Xu; M Shiung; P C O'Brien; R Cha; D Knopman; R C Petersen
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

Review 7.  A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile.

Authors:  Konstantine K Zakzanis; Simon J Graham; Zachariah Campbell
Journal:  Neuropsychol Rev       Date:  2003-03       Impact factor: 7.444

8.  Premorbid cognitive testing predicts the onset of dementia and Alzheimer's disease better than and independently of APOE genotype.

Authors:  J Cervilla; M Prince; S Joels; S Lovestone; A Mann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

9.  A complex dietary supplement augments spatial learning, brain mass, and mitochondrial electron transport chain activity in aging mice.

Authors:  Vadim Aksenov; Jiangang Long; Jiankang Liu; Henry Szechtman; Parul Khanna; Sarthak Matravadia; C David Rollo
Journal:  Age (Dordr)       Date:  2011-11-27

10.  Measuring longitudinal change in the hippocampal formation from in vivo high-resolution T2-weighted MRI.

Authors:  Sandhitsu R Das; Brian B Avants; John Pluta; Hongzhi Wang; Jung W Suh; Michael W Weiner; Susanne G Mueller; Paul A Yushkevich
Journal:  Neuroimage       Date:  2012-01-28       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.